KR101904800B1 - Cosmetic composition for anti-oxidation or skin whintening containing extract of medicinal herbs mixture - Google Patents
Cosmetic composition for anti-oxidation or skin whintening containing extract of medicinal herbs mixture Download PDFInfo
- Publication number
- KR101904800B1 KR101904800B1 KR1020110137197A KR20110137197A KR101904800B1 KR 101904800 B1 KR101904800 B1 KR 101904800B1 KR 1020110137197 A KR1020110137197 A KR 1020110137197A KR 20110137197 A KR20110137197 A KR 20110137197A KR 101904800 B1 KR101904800 B1 KR 101904800B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- cosmetic composition
- skin
- mixture
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 각종 물리적, 화학적 및 환경적 요인 등에 의하여 생성되는 활성산소로 인한 자유라디칼을 소거할 수 있는 항산화용 또는 멜라닌 색소 침착을 막아 피부 미백 효능이 탁월한 화장료 조성물에 관한 것으로, 보다 상세하게는 한약재 혼합 추출물을 함유하여 피부 속 활성 산소에 의한 산화를 억제함으로써 항산화 효과가 탁월하며, 피부 멜라닌 색소의 침착을 저해하여 미백효과가 뛰어난 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition which is excellent in skin whitening efficacy by preventing antioxidation or melanin pigment deposition which can eliminate free radicals caused by active oxygen generated by various physical, chemical and environmental factors, and more particularly, The present invention relates to a cosmetic composition which is excellent in antioxidative effect by inhibiting oxidation by active oxygen in the skin by containing a mixed extract and is excellent in whitening effect by inhibiting deposition of skin melanin pigment.
Description
본 발명은 각종 물리적, 화학적 및 환경적 요인 등에 의하여 생성되는 활성산소로 인한 자유라디칼을 소거할 수 있는 항산화용 또는 멜라닌 색소 침착을 막아 피부 미백 효능이 탁월한 화장료 조성물에 관한 것으로, 보다 상세하게는 한약재 혼합 추출물을 함유하여 피부 속 활성 산소에 의한 산화를 억제함으로써 항산화 효과가 탁월하며, 피부 멜라닌 색소의 침착을 저해하여 미백효과가 뛰어난 화장료 조성물에 관한 것이다.
The present invention relates to a cosmetic composition which is excellent in skin whitening efficacy by preventing antioxidation or melanin pigment deposition which can eliminate free radicals caused by active oxygen generated by various physical, chemical and environmental factors, and more particularly, The present invention relates to a cosmetic composition which is excellent in antioxidative effect by inhibiting oxidation by active oxygen in the skin by containing a mixed extract and is excellent in whitening effect by inhibiting deposition of skin melanin pigment.
체내 효소계, 환원대사, 화학약품, 공해물질 및 광화학반응 등의 각종 물리적, 화학적 및 환경적 요인 등에 의하여 생성되는 활성산소는 세포구성 성분들인 지질, 단백질, 당 및 DNA 등에 대하여 비선택적, 비가역적인 파괴작용을 함으로써 세포노화 또는 암을 비롯한 각종 질병을 일으키는 것으로 알려져 있다. 또한 이들 활성산소에 의한 지질과산화의 결과로 생성되는 지질과산화물을 비롯한 여러가지 체내 과산화물도 세포에 대한 산화적 파괴를 일으켜 각종 기능장애를 야기함으로써 여러 가지 질병의 원인이 되기도 한다. 따라서, 이와 같은 자유 라디칼을 소거할 수 있는 화합물(free radical scavengers) 또는 과산화물 생성 억제물질과 같은 항산화제들이 이들 산화물들에 기인하는 노화 및 각종 질환의 억제 또는 치료제로서 기대된다.Active oxygen generated by various physical, chemical and environmental factors such as in vivo enzymes, reductive metabolism, chemicals, pollutants and photochemical reactions can cause non-selective and irreversible destruction of cellular components such as lipids, proteins, It is known to cause various diseases including cancer and senescence. In addition, various peroxides such as lipid peroxides produced as a result of lipid peroxidation by these active oxygen also cause oxidative destruction to cells and cause various dysfunctions, thereby causing various diseases. Accordingly, antioxidants such as free radical scavengers or peroxidation-inhibiting substances are expected to be used as agents for inhibiting or treating various diseases caused by these oxides.
한편, 사람의 피부색을 결정하는 데는 여러 가지 요인들이 관여하는데, 그 중에서도 멜라닌 색소를 만드는 멜라노사이트(melanocyte)의 활동성, 혈관의 분포, 피부의 두께 및 카로티노이드, 빌리루빈 등의 인체 내외의 색소 함유 유무 등의 요인들이 중요하다.On the other hand, various factors are involved in determination of human skin color. Among them, activity of melanocyte which makes melanin pigment, distribution of blood vessels, thickness of skin, presence of pigment inside and outside of human body such as carotinoid and bilirubin The factors of importance are.
이중 특히 가장 중요한 요인은 인체 내의 멜라노사이트에서 타이로시나제 등의 여러 효소가 작용하여 생성되는 멜라닌이라는 흑색 색소이다. 이 멜라닌 색소의 형성에는 유전적 요인, 호르몬 분비, 스트레스 등과 관련된 생리적 요인 및 자외선 조사 등과 같은 환경적 요인 등이 영향을 미친다.Especially, the most important factor is melanin, a melanin pigment produced by the action of various enzymes such as tyrosinase in melanocytes in the human body. The formation of melanin pigment affects genetic factors, hormonal secretion, physiological factors such as stress, and environmental factors such as ultraviolet irradiation.
신체 피부의 멜라닌 세포에서 생성되는 멜라닌 색소는 검은 색소와 단백질의 복합체 형태를 갖는 페놀계 고분자 물질로서, 태양으로부터 조사되는 자외선을 차단하여 진피 이하의 피부기관을 보호해주는 동시에 피부 생체 내에 생겨난 자유 라디칼 등을 잡아주는 등 피부 내 단백질과 유전자들을 보호해주는 유용한 역할을 담당한다.The melanin pigment produced in melanocytes of body skin is a phenolic polymer substance having a complex form of black pigment and protein. It protects the subcutaneous skin organs by blocking ultraviolet rays irradiated from the sun, and at the same time, free radicals And protects proteins and genes in the skin.
이와 같이 피부 내, 외부의 스트레스적 자극에 의해 생겨난 멜라닌은, 스트레스가 사라져도 피부 각질화를 통해서 외부로 배출되기 전까지는 없어지지 않는 안정한 물질이다. 그러나 멜라닌이 필요 이상으로 많이 생기게 되면 기미나 주근깨, 점 등과 같은 과색소 침착증을 유발하여 미용상으로 좋지 않은 결과를 가져오게 된다. Melanin, which is produced by stress stimuli inside and outside of the skin, is a stable substance that does not disappear until the skin is excreted through skin keratinization even if the stress disappears. However, when melanin is produced more than necessary, it induces hypercholesterolemia such as spots, freckles, and dots, resulting in poor cosmetic results.
또한, 레저 인구의 증가로 외부에서 활동하는 것을 즐기는 사람들이 많아지면서 자외선에 의한 멜라닌 색소 침착을 막고자 하는 요구가 늘어나게 되었다. In addition, as the number of people enjoying outdoor activities increased due to the increase in the leisure population, the demand for preventing melanin pigmentation due to ultraviolet rays increased.
이와 같은 요구에 부응하여 종전부터 아스코르빈산, 코지산, 알부틴, 하이드로퀴논, 글루타치온 또는 이들의 유도체들, 또는 타이로시나제 저해활성을 가진 물질들을 화장료나 의약품에 배합하여 사용하여 왔으나, 이들의 불충분한 미백효과, 피부에 대한 안전성 문제, 화장료에 배합 시 나타나는 제형 및 안정성의 문제 등으로 인해 그 사용이 제한되고 있다.In response to such demands, substances having ascorbic acid, kojic acid, arbutin, hydroquinone, glutathione, derivatives thereof, or thyrocinase inhibiting activity have been conventionally used in cosmetics or pharmaceuticals, The use thereof is limited due to insufficient whitening effect, safety problem to skin, formulation and stability of formulation in cosmetics, and the like.
세신은 쥐방울과에 속하는 다년생 초본식물로, 근경에 마디가 많으며 원줄기 끝에서 2개의 잎이 나와 마주 퍼진다. 족두리풀의 뿌리를 건조시킨 약재로 세신이라는 명칭은 뿌리가 지극히 가늘고 몹시 매운 맛을 띠고 있어서 명명된 것이다. 이두 향명으로는 세심(洗心)이라 하였으며, 시, 소신(少辛), 세초(細草)라고도 하였다. 잎은 심장형이며 너비는 5∼10㎝로서 가장자리가 밋밋하다. 꽃은 홍자색으로 잎이 나오려고 할 때 잎 사이에서 1개씩 나온다. 열매는 장과상이고 끝에 화피열편(花被裂片)이 달려 있으며 종자가 20개 정도 들어 있다. 뿌리는 5∼7월에 채취하여 그늘에서 말린다. 약성은 온화하고 맛이 맵다. 효능은 감기로 코가 막히거나 콧물이 계속 흐르고 인후 부위에서 분비물이 계속 배출되며 땀이 잘 안 날 때에 발한시키면서 병원균을 체외로 배출시킨다. 또 감기로 열이 심하고 특히 두통이 심하여 견딜 수 없을 때에 긴요하다. 만성기관지염이나 기관지확장증으로 인하여 대량의 가래를 배출하면서 기침을 심하게 할 때에 진해작용도 한다. 이 밖에 구내염에 분말로 만들어 뿌려 주면 곧 치유된다. 다만, 기운이 허약하고 땀을 많이 흘리거나 빈혈로 두통이 있을 때는 사용하지 않으며, 여로(藜蘆)와 같이 배합해서도 안 된다. 민간에서는 이가 아픈 곳에 물고 있으면 곧 진통이 된다고 하여 진통제로 이용한다. 대표적인 처방으로는 세신탕이 있다.Seeshin is a perennial herbaceous plant belonging to the rat and bell. There are many nodes in the rhizome, and two leaves come out from the end of the main stem. It is a medicinal herb that dried the roots of bamboo shoots. It is named after the roots are extremely thin and very spicy. It was called "Shin-myeon" in the name of Lee Duk-myun, and it was also called "poetry", "Sosin" and "Seko". Leaves are heart-shaped and have a width of 5 to 10 cm with flat edges. The flower is reddish purple, and one leaf comes out when it is going to come out. Fruit is long bract, with lanceolate on the end and about 20 seeds. Root is collected in May-July and dried in the shade. The weakness is mild and the taste is spicy. The efficacy of the cold is blocked by the nose or runny nose continues to flow through the throat discharge of the secretion of perspiration when the sweating is not good, and the virus out of the body. It is also critical when the fever is severe with a cold, especially when the headache is severe and can not withstand. Chronic bronchitis or bronchiectasis due to a large amount of sputum, while coughing severely when the jinhae also acts. In addition, it will be healed if it is made into powder for stomatitis. However, it should not be used when weakness, weakness, sweating, anemia, or headache are present. In the private sector, it is used as an analgesic because it becomes pain when it is bitten in a sick place. A typical prescription is Sechin-tang.
천궁은 산형과에 속하는 다년생 초본식물이다. 향명으로는 궁궁이라고 하며, 학명은 Cnidium officinale MAKINO이다. 중국산 식물로 우리나라에서 흔히 재배되고 있는데, 높이는 30∼60㎝이고 곧추 자라며 가지가 갈라진다. 잎은 어긋나고 2회우상복엽이며 근생엽은 엽병이 길고 경생엽(莖生葉)은 위로 올라갈수록 점차 작아지며 밑부분이 엽초(葉?: 잎깍지)로 되어 원줄기를 감싸고 소엽은 난형 또는 피침형으로서 결각상(缺刻狀)의 톱니와 더불어 예리한 톱니가 있다. 꽃은 8월에 피며 가지 끝과 원줄기 끝에서 큰 산형화서가 발달한다. 어린순은 나물로 먹고 뿌리줄기는 건조시켜 약재로 이용한다. 성분은 방향성정유를 다량 함유하고 있어서 냄새가 좋다. 주성분은 크니딜라이드(cnidilide), 네오크니딜라이드(neocnidilide), 리구스틸라이드(ligustilide) 등이 있다. 동물을 통한 약리적 작용실험에서 중추신경계통에 작용하여 진정효과가 있음을 확인하였으며, 약하지만 지속적인 혈압강하작용도 확인되었다. 평활근에 대한 실험에서는 자궁의 수축력을 증대시켜 주고 또 살균작용이 있어서 대장균, 이질균, 녹농균, 피부진균의 발육을 억제시키는 효과가 나타났다. 이 약은 약성이 온화하고 맛이 시어서 체내에 들어가서는 혈액순환을 왕성하게 해주고 통증을 가라앉히는 진통효과가 있다. 그러므로 두통에도 자주 응용된다. 부인에게 있어서는 월경불순, 월경통, 산후복통과 어지러운 증상을 없애준다. 또, 간장의 기능을 활성화시켜 주고 빈혈에 복용하면 조혈작용으로 효험을 얻게 된다. 그리고 심장근육의 수축부전으로 인한 심장 부위의 통증에도 증상을 호전시키고 있다. 허리와 다리의 골격이 약하고 근육에 경련을 자주 일으키는 사람이 복용하면 그와 같은 증상이 개선된다. 황련(黃連)과의 배합을 꺼리고 오래 복용하면 원기를 손상시킨다. 민간에서는 옷장에 넣어두어 좀을 예방한다. 대표적인 처방으로 궁귀탕(芎歸湯)이 있는데 부인의 해산을 전후해서 많이 쓰인다. 천궁은 한방에서 많이 쓰이는 약의 하나이다.It is a perennial herbaceous plant belonging to the mountain type. The name is Cunidium officinale MAKINO. It is a Chinese plant and it is commonly cultivated in Korea. Its height is 30 ~ 60㎝, it grows straight and branches are split. Leaves are alternate phyllotaxis, and the leaves are long and petiole is long. Leaves are gradually smaller as they go up, and the lower part is wrapped around the main stem as leaf leaves. Leaves are ovate or lanceolate, There are sawtooths with missing teeth and sharp sawtooths. Flowers bloom in August, and large phloem episodes develop at the ends of the branches and the main stem. The young seeds eat as herbs and the rootstock is dried and used as medicinal materials. The ingredient contains a large amount of aromatic essential oil, so it has a good smell. The main components are cnidilide, neocnidilide, and ligustilide. In pharmacological experiments with animals, it was found to have a sedative effect on the central nervous system, and a weak but sustained hypotensive effect was also confirmed. In the experiment on smooth muscle, the contraction power of the uterus was increased, and the sterilizing action was shown to have the effect of inhibiting the development of Escherichia coli, Dysentery, Pseudomonas aeruginosa, and Dermatophyte. This medicine is mild and tasteless, it enters the body and makes the circulation of blood vigorous and calms the pain. Therefore, it is often applied to headache. For her, she removes menstrual irregularities, dysmenorrhea, abdominal pain and dizziness. In addition, when the liver function is activated and anemia is taken, the hematopoietic effect is obtained. And the heart muscle pain caused by the contraction of the heart muscle is also improving symptoms. If the skeleton of the lower back and legs is weak and the person often causes muscle spasms, such symptoms will be improved. Reluctant to blend with Huang Rin (黄连) and take a long time to damage the spirit. In the private sector, they are kept in the closet to prevent mosquitoes. As a typical prescription, there is a mungwangtang (芎 帰 湯), which is used after the dissolution of his wife. It is one of the most used medicine in one room.
행인은 중국산의 장미과에 속하는 Prunus mandshurica var . glabra , Prunus mandshurica , Prunus sibirica의 건조한 종자이다. 진해·거담 효능이 있어 민간에서는 해소·천식·기관지염·급성간염 등에 약으로 쓴다. 행인의 주요성분은 구연산, 말산, 아미그달린, 올레인 등이며 그 외 칼륨과 인이 특히 많이 들어 있고, 당질, 칼슘, 나트륨, 섬유질, 비타민A, B, C 등을 함유하고 있다. 거칠고 건조한 피부에 보습과 영양을 주며, 잔주름, 기미, 주근깨 제거, 미백, 각질 제거 효과가 있다. 본초강목(本草綱目)에는 살구씨를 이용한 치료방법이 200여 가지나 기록돼 있을 정도로 그 쓰임새와 약효가 많아 실제로 ‘약방의 살구’라는 별칭으로 불리기도 하는데, 행인을 갈아서 만든 팩은 주로 기미, 주근깨 등 피부 색소 침착,종기, 부스럼 등에 사용된다.
The passerby belongs to the rose family of Chinese origin Prunus mandshurica var . glabra , Prunus mandshurica , Prunus It is a dry seed of sibirica . Because it is Jinhae, goddess effect, it is used for medicine of relieving, asthma, bronchitis, acute hepatitis in private. Calcium, sodium, fiber, vitamins A, B and C are the main components of passerine, and they contain citric acid, malic acid, amigalline, and olein. It moisturizes and nourishes the rough and dry skin, and has fine lines, spots, freckles, whitening, exfoliating effect. There are more than 200 treatments using apricot seeds in the herbaceous gangmok (herbaceous seed), and they are often called 'apricot', because they have many uses and medicinal effects. Skin pigmentation, swelling, swelling and so on.
이에 본 발명자들은 상기 문제점을 해결하고, 보다 우수한 항산화 및 미백 원료를 찾고자 하는 연구의 일환으로 여러 천연물을 검색한 결과 세신, 천궁 및 행인으로 이루어진 한약재 혼합 추출물이 단순 추출물에 비해 항산화 및 미백 효과가 현저하게 우수하다는 것을 발견하여 본 발명을 완성하였다.As a result of searching for natural antioxidants and whitening raw materials, the present inventors searched for natural products, and found that the herbal extracts of Seosin, Seungkung, And thus the present invention has been completed.
따라서, 본 발명의 목적은 세신, 천궁 및 행인 추출물을 유효성분으로 함유하는 화장료 조성물을 제공하는 것이다. 본 발명의 또다른 목적은 세신, 천궁 및 행인 추출물을 유효성분으로 함유하여 항산화용 화장료 조성물을 제공하는 것이다. 본 발명의 또다른 목적은 세신, 천궁 및 행인 추출물을 유효성분으로 함유하여 자유라디칼 소거능을 갖는 화장료 조성물을 제공하는 것이다. 본 발명의 또다른 목적은 세신, 천궁 및 행인 추출물을 유효성분으로 함유하여 피부 미백효능을 갖는 화장료 조성물을 제공하는 것이다.
Accordingly, it is an object of the present invention to provide a cosmetic composition containing an extract of Sezin, Astragalus membranaceus, and Angela giganteus as active ingredients. Yet another object of the present invention is to provide a cosmetic composition for antioxidation, which contains an extract of Sezin, Astragalus membranaceus and Angelicae Radix as an active ingredient. Yet another object of the present invention is to provide a cosmetic composition having a free radical scavenging ability, which comprises an extract of Sezin, Astragalus membranaceus and Angelica keiskei as an active ingredient. Another object of the present invention is to provide a cosmetic composition having a skin whitening effect by containing an extract of Sezin, Astragalus membranaceus and Candida extract as an active ingredient.
상기한 목적을 달성하기 위하여, 본 발명은 세신 추출물, 천궁 추출물 및 행인 추출물을 유효성분으로 함유하는 화장료 조성물을 제공한다.In order to attain the above object, the present invention provides a cosmetic composition comprising an acanthomex extract, a cinnabar extract, and an extract from a passerine as an active ingredient.
이하, 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명의 세신 추출물, 천궁 추출물 및 행인 추출물은 당업계에 통상적인 방법에 따라 수득될 수 있으며, 그 방법은 특별히 한정되지 않는다. 구체적인 예를 들면, 건조된 세신 또는 천궁 또는 행인에 에탄올을 더 첨가하여 유용성 성분을 추출한 후, 환류추출 후 침적시키고, 여과 및 원심분리를 통하여 분리된 여액을 감압농축과정을 거쳐 세신 또는 천궁 또는 행인 추출물을 얻을 수 있다.The sesquiterpenoid extract, astragalus extract, and passerine extract of the present invention can be obtained according to a method common in the art, and the method is not particularly limited. Specifically, ethanol is further added to the dried sesquinia or cinnabar or passerine to extract an oil-soluble component, followed by reflux extraction, immersion, filtration and centrifugation to separate the filtrate under reduced pressure, An extract can be obtained.
본 발명의 세신, 천궁 및 행인 추출물은 조성물 총 중량에 대하여 총 합이 0.001 ~ 20 중량%, 보다 바람직하게는 0.005 ~ 10 중량%의 양으로 함유된다. 0.001 %미만에서는 원하는 효과를 기대할 수 없으며, 20 중량%를 초과하는 경우에는 변취 등 화장품 변성의 우려가 있고 화장품 제형의 점도 조절이 쉽지 않으며 에멀젼 제형 제조시 전상이 일어나기 쉽기 때문에 화장료 제형으로서 개발하기 어렵고 생산 경제성도 떨어지게 된다.The total amount of the sesquin, licorice extract and callus extract of the present invention is 0.001 to 20 wt%, more preferably 0.005 to 10 wt%, based on the total weight of the composition. If it is less than 0.001%, a desired effect can not be expected. If it is more than 20% by weight, there is a risk of denaturation of cosmetics such as rinsing, viscosity control of cosmetic formulations is not easy, and since a phase is liable to occur during preparation of emulsion formulations, Production economics also fall.
본 발명의 화장료 조성물에 함유된 세신, 천궁 및 행인 추출물의 혼합비는 1 : 1~3 : 1~3 이다. 이러한 혼합비를 벗어나면 성분의 시너지 효과를 기대하기 어렵다. The mixing ratio of citrine, astragalus and goat extract contained in the cosmetic composition of the present invention is 1: 1 to 3: 1 to 3. It is difficult to expect the synergistic effect of the components if they exceed the mixing ratio.
본 발명에서 제공하는 화장료 조성물은 상기와 같은 세신 추출물과 천궁 추출물의 혼합 추출물을 함유함으로써 자외선, 기타 외부 유해 성분들로부터 유발되는 피부 산화 반응을 차단하는 효과 및 피부 멜라닌 색소의 침착을 저해하여 미백효과를 실질적으로 구현할 수 있다.The cosmetic composition provided by the present invention contains a mixture of the sesquin extract and the cynomolgus bark extract as described above, thereby preventing the skin oxidation reaction induced from ultraviolet rays and other external harmful components and inhibiting the deposition of the skin melanin pigment, Can be practically implemented.
본 발명의 화장료 조성물은 피부 항산화 및 미백용 화장품에 사용될 수 있으며 그 제형에 있어서는 특별히 한정되는 바가 없고 예를 들면 유액, 크림, 화장수, 에센스, 팩, 젤, 파우더, 립스틱, 메이컵 베이스, 파운데이션, 로션 또는 피부 점착 타입 화장료의 제형 혹은 경피투여형 제형일 수 있다.
The cosmetic composition of the present invention can be used in cosmetics for skin antioxidation and whitening, and is not particularly limited in its formulation. Examples of such cosmetic compositions include emulsions, creams, lotions, essences, packs, gels, powders, lipsticks, makeup bases, Lotion or skin adhesive type cosmetics, or a transdermal dosage form.
본 발명에서는 세신, 천궁 및 행인 혼합 추출물을 함유하는 화장료 조성물이 DPPH 생성 억제 효능을 갖는 항산화 및 자외선(ultraviolet rays; UV)에 의해 생성된 색소 침착을 개선하는 효과에 기인한 미백 효과를 나타낼 수 있음을 확인하였다. 따라서 본 발명에 의한 세신, 천궁 및 행인 혼합 추출물은 항산화, 미백용 화장료 조성물 또는 약학 조성물로서 매우 유용하게 사용될 수 있다.
In the present invention, a cosmetic composition containing a mixture of sesquin, celadon and passerine may exhibit a whitening effect due to an effect of improving antioxidative and ultraviolet rays (UV) -containing pigment deposits with DPPH production inhibitory effect Respectively. Therefore, according to the present invention, the mixed extract of Sezin, Tongkung, and Candy can be very usefully used as a cosmetic composition or a pharmaceutical composition for antioxidant, whitening.
이하, 실시예 및 실험예를 들어 본 발명을 보다 구체적으로 설명하나, 본 발명의 권리범위가 이들에 의해 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to Examples and Experimental Examples, but the scope of the present invention is not limited thereto.
[[ 비교예Comparative Example 1] 세신 추출물 제조 1] Preparation of sesquic acid extract
건조 시킨 세신 300g에 70% 에탄올 2ℓ를 넣고, 3회 환류 추출한 후, 15℃에서 1일간 침적시켰다. 그 다음, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액을 감압 농축하여 추출물 24g을 수득하였다.
To 300 g of dried sesquin were added 2 L of 70% ethanol, refluxed three times, and then immersed at 15 DEG C for 1 day. Then, the residue and the filtrate were separated by filtration through a filter cloth and centrifugation, and the separated filtrate was concentrated under reduced pressure to obtain 24 g of an extract.
[[ 비교예Comparative Example 2] 천궁 추출물 제조 2] Manufacture of astragalus extract
건조 시킨 천궁 300g에 70% 에탄올 2ℓ를 넣고, 3회 환류 추출한 후, 15℃에서 1일간 침적시켰다. 그 다음, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액을 감압 농축하여 추출물 33g을 수득하였다.
To 300 g of dried cilia, 2 L of 70% ethanol was added, and the mixture was refluxed three times and then immersed at 15 DEG C for 1 day. Then, the residue and the filtrate were separated by filtration and centrifugation through a filter cloth, and the separated filtrate was concentrated under reduced pressure to obtain 33 g of an extract.
[[ 비교예Comparative Example 3] 행인 추출물 제조 3] Production of passerine extract
건조 시킨 행인 300g에 70% 에탄올 2ℓ를 넣고, 3회 환류 추출한 후, 15℃에서 1일간 침적시켰다. 그 다음, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액을 감압 농축하여 추출물 35g을 수득하였다.
To 300 g of the dried dish, 2 L of 70% ethanol was added, and the mixture was refluxed three times and then immersed at 15 DEG C for 1 day. Then, the filtrate and the filtrate were separated by filtration through a filter cloth and centrifugation, and the separated filtrate was concentrated under reduced pressure to obtain 35 g of an extract.
[[ 실시예Example 1] 세신, 천궁 및 행인의 혼합 추출물 제조 1] Manufacture of mixed extract of sezin
비교예 1의 세신 추출물 20g, 비교예 2의 천궁 추출물 20g 및 비교예 3의 행인 추출물 20g을 혼합한 뒤 70% 에탄올 수용액 400ml 를 넣고 완전히 용해시킨 다음 15℃에서 1일간 침적시켰다. 그 후, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액을 감압 농축하여 세신, 천궁 및 행인 추출물의 혼합물 46g을 얻었다.
20 g of the sesquicin extract of Comparative Example 1, 20 g of the cucurbitaceae extract of Comparative Example 2 and 20 g of the extract of Comparative Example 3 were mixed and then 400 ml of 70% aqueous ethanol solution was completely dissolved therein, followed by immersion for one day at 15 ° C. Thereafter, the residue and the filtrate were separated by filtration and centrifugation through a filter cloth, and the separated filtrate was concentrated under reduced pressure to obtain 46 g of a mixture of seshinum, astragalus and goat extract.
[[ 실시예Example 2] 세신, 천궁 및 행인의 혼합 추출물 제조 2] Manufacture of mixed extract of Sezin, Taeunggung, and passerine
비교예 1의 세신 추출물 12g, 비교예 2의 천궁 추출물 36g 및 비교예 3의 행인 추출물 12g을 혼합한 뒤 70% 에탄올 수용액 450ml 를 넣고 완전히 용해시킨 다음 15℃에서 1일간 침적시켰다. 그 후, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액을 감압 농축하여 세신, 천궁 및 행인 추출물의 혼합물 49g을 얻었다.
12 g of the sesquicin extract of Comparative Example 1, 36 g of the cucurbitaceae extract of Comparative Example 2 and 12 g of the extract of Comparative Example 3 were mixed, 450 ml of a 70% aqueous ethanol solution was completely dissolved therein, and the mixture was immersed at 15 캜 for 1 day. Thereafter, the residue and the filtrate were separated by filtration through a filter cloth and centrifugation, and the separated filtrate was concentrated under reduced pressure to obtain 49 g of a mixture of the extract of Seishin, Taeungguk, and Raney.
[[ 실시예Example 3] 세신, 천궁 및 행인의 혼합 추출물 제조 3] Manufacture of mixed extract of sezin
비교예 1의 세신 추출물 12g, 비교예 2의 천궁 추출물 12g 및 비교예 3의 행인 추출물 36g을 혼합한 뒤 70% 에탄올 수용액 450ml 를 넣고 완전히 용해시킨 다음 15℃에서 1일간 침적시켰다. 그 후, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액을 감압 농축하여 세신, 천궁 및 행인 추출물의 혼합물 48g을 얻었다.
12 g of the cetin extract of Comparative Example 1, 12 g of the cinnabar extract of Comparative Example 2, and 36 g of the extract of Comparative Example 3 were mixed, 450 ml of a 70% aqueous ethanol solution was added thereto, and the mixture was completely dissolved and immersed at 15 캜 for 1 day. Thereafter, the residue and the filtrate were separated by filtration through a filter cloth and centrifugation, and the separated filtrate was concentrated under reduced pressure to obtain 48 g of a mixture of Seishin, Tongkung, and Candy Extract.
[[ 실시예Example 4] 세신, 천궁 및 행인의 혼합 추출물 제조 4] Manufacture of mixed extract of sezin
비교예 1의 세신 추출물 8.5g, 비교예 2의 천궁 추출물 25.5g 및 비교예 3의 행인 추출물 25.5g을 혼합한 뒤 70% 에탄올 수용액 450ml 를 넣고 완전히 용해시킨 다음 15℃에서 1일간 침적시켰다. 그 후, 여과포 여과와 원심분리를 통해 잔사와 여액을 분리하고, 분리된 여액을 감압 농축하여 세신, 천궁 및 행인 추출물의 혼합물 48g을 얻었다.
8.5 g of the sesquicin extract of Comparative Example 1, 25.5 g of the cucurbitaceae extract of Comparative Example 2, and 25.5 g of the extract of Comparative Example 3 were mixed and then 450 ml of a 70% aqueous ethanol solution was completely dissolved therein, followed by immersion for one day at 15 ° C. Thereafter, the residue and the filtrate were separated by filtration through a filter cloth and centrifugation, and the separated filtrate was concentrated under reduced pressure to obtain 48 g of a mixture of Seishin, Tongkung, and Candy Extract.
[[ 시험예Test Example 1] 항산화 효과 시험( 1] Antioxidant effect test ( DPPHDPPH testtest ))
유기 라디칼인 DPPH(1,1-diphenyl-2-picryl hydrazyl)의 환원에 의해(항산화제는 산화됨) 발생되는 흡광도의 변화를 통해 항산화능을 평가하는 방법을 사용하였다. 하기 예들에 의해 DPPH의 산화가 억제되어 흡광도가 대조군에 비해 감소되는 정도를 측정하여, 대조군의 흡광도에 비해서 50% 이하의 흡광도를 나타내는 농도를 유효 항산화 농도로 평가하였다.The antioxidant activity was evaluated by the change of the absorbance generated by the reduction of the organic radical, DPPH (1,1-diphenyl-2-picryl hydrazyl) (the antioxidant was oxidized). The degree to which the oxidation of DPPH was suppressed and the absorbance was decreased as compared with the control group was measured by the following examples, and the concentration showing an absorbance of 50% or less as compared with the absorbance of the control group was evaluated as the effective antioxidant concentration.
100μM(in 에탄올) DPPH 용액 190㎕와 상기 비교예, 실시예 추출물 1~4와 비교 시료 및 대조시료를 각각 10㎕ 넣어 반응액을 만들고 37℃에서 30분간 반응시킨 후 540nm에서 흡광도를 측정하였다. 대조시료로는 널리 사용하고 있는 합성 항산화제 트롤록스(Trolox)를 사용하였다.The reaction solution was prepared by adding 190 μl of 100 μM (in ethanol) DPPH solution, 10 μl each of the comparative sample, the extracts of Examples 1 to 4 and the comparative sample and the control sample, reacting at 37 ° C. for 30 minutes, and measuring the absorbance at 540 nm. As a control sample, a synthetic antioxidant Trolox, which is widely used, was used.
각 물질의 DPPH 분석 결과를 하기 표 1에 나타내었다. The results of DPPH analysis of each material are shown in Table 1 below.
(혼합 비율=1:1:1)Seisin, Taeunggung, Chungbuk mixed extract
(Mixing ratio = 1: 1: 1)
(혼합 비율=1:3:1)Seisin, Taeunggung, Chungbuk mixed extract
(Mixing ratio = 1: 3: 1)
(혼합 비율=1:1:3)Seisin, Taeunggung, Chungbuk mixed extract
(Mixing ratio = 1: 1: 3)
(혼합 비율=1:3:3)Seisin, Taeunggung, Chungbuk mixed extract
(Mixing ratio = 1: 3: 3)
표 1에서 확인할 수 있는 바와 같이, 본 발명에 의한 세신, 천궁 및 행인의 혼합 추출물의 실시예 1~4가 비교예의 단일 추출물 보다 좋은 활성을 보이고 당업계 공지의 항산화제인 트롤록스와 유사한 항산화 능을 확인할 수 있었다.
As can be seen in Table 1, Examples 1 to 4 of the mixed extract of Seixin, Tongkung and Chinin according to the present invention exhibited better activity than the single extract of the comparative example and showed antioxidant ability similar to Trolox, an antioxidant known in the art I could confirm.
[[ 시험예Test Example 2] 쥐의 색소세포를 이용한 멜라닌 생성 억제효과 측정 2] Measurement of inhibitory effect of melanin formation by mouse pigment cells
상기 비교예 및 실시예 추출물들과 대조시료의 멜라닌 생성 억제효과를 알아보기 위하여 쥐의 색소세포를 이용하여 측정하였다.In order to examine the inhibitory effect of the extracts of the comparative examples and the examples and the control sample on melanin production, rat pigment cells were used.
먼저, C57BL/6 마우스 유래의 쥐의 색소세포(Mel-Ab cell)(Dooley, T.P. et al, Skin pharmacol, 7, pp 188-200)를 DMEM에 10% 우태반 혈청, 100nM 12-O-테트라데카노일포르볼-13-아세트산 (12-O-tetradecanoylphorbol-13-acetate), 1nM 콜레라 독소(cholera toxin)을 첨가한 배지에서 37℃, 5% CO2의 조건에서 배양하였다. 배양된 Mel-Ab 세포를 0.25% 트립신-EDTA로 떼어내고, 24-웰 플레이트에 105 세포/웰(cells/well)의 농도로 세포를 배양하고 이틀째부터 3일 연속으로 10ppm의 각 시험물질로 하이드로퀴논, 상기 비교예, 실시예 추출물들과 대조시료를 가하여 배양하였다. 이때, 상기 하이드로퀴논은 양성대조군으로 사용하였다. 그 다음 배양액을 제거하고, PBS로 세척한 후, 1N 수산화나트륨으로 세포를 녹여 400nm에서 흡광도를 측정한 다음, 하기 수학식 1에 따라 멜라닌 생성 억제율을 계산하여 그 결과를 표 2에 나타내었다(Dooley의 방법).
First, the mouse melanoma cells (Dooley, TP et al, Skin pharmacol, 7, pp 188-200) derived from C57BL / 6 mice were inoculated into DMEM with 10% fetal bovine serum, 100 nM 12- The cells were cultured in a medium supplemented with 12-O-tetradecanoylphorbol-13-acetate and 1 nM cholera toxin at 37 ° C and 5% CO 2 . The cultured Mel-Ab cells were removed with 0.25% trypsin-EDTA, the cells were cultured at a concentration of 10 5 cells / well in a 24-well plate, and 10 ppm of each test substance Hydroquinone, the above-mentioned Comparative Examples and the extracts of Examples were added to a control sample and cultured. At this time, the hydroquinone was used as a positive control. Then, the culture solution was removed, washed with PBS, and the cells were dissolved with 1 N sodium hydroxide, and the absorbance at 400 nm was measured. The rate of inhibition of melanin production was calculated according to the following formula (1) Method).
상기 표 2에 나타나는 바와 같이, 본 발명에 의해 수득한 세신, 천궁 및 행인혼합 추출물의 실시예 1~4가 비교예의 단일 추출물 보다 좋은 멜라닌 생성 억제율을 보이는 것으로 확인되었고, 특히 혼합 추출물들이 하이드로 퀴논과 유사한 정도의 멜라닌 생성 억제율을 보이는 것을 확인하였다.As shown in the above Table 2, Examples 1 to 4 of the mixed extract of Seixin, Tongkung and Chinju obtained by the present invention showed better melanin production inhibitory rate than the single extract of Comparative Example. Especially, the mixed extracts showed hydroquinone And a similar degree of inhibition of melanin production was observed.
Claims (6)
상기 혼합물은 세신 추출물, 천궁 추출물 및 행인 추출물을 중량 기준으로 1 : 1~3 : 1~3의 비율로 혼합한 것임을 특징으로 하는, 피부 미백용 화장료 조성물.
A cosmetic composition for skin whitening comprising as an active ingredient a mixture of sesquin extract, cinnabar extract, and goat extract,
The cosmetic composition for skin whitening according to claim 1, wherein the mixture is a mixture of sesquin extract, cinnabar extract, and callus extract in a ratio of 1: 1 to 3: 1 to 3 by weight.
The cosmetic composition for skin whitening according to claim 1, wherein the content of the mixture is 0.001 to 20% by weight based on the total weight of the composition.
The composition according to claim 1, wherein the mixture is a mixture of sesamin, cinnabar, and goat extract in a weight ratio of 1: 1: 1, 1: 3: 1, 1: 1: 3, or 1: 3: 3 Wherein the cosmetic composition is a cosmetic composition for skin whitening.
[Claim 5] The cosmetic composition for skin whitening according to claim 4, wherein the mixture is a mixture of sesqui extract, cinnabar extract, and passerine extract in a weight ratio of 1: 3: 3.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110137197A KR101904800B1 (en) | 2011-12-19 | 2011-12-19 | Cosmetic composition for anti-oxidation or skin whintening containing extract of medicinal herbs mixture |
| JP2012274402A JP6154606B2 (en) | 2011-12-19 | 2012-12-17 | Antioxidant or whitening cosmetic composition containing an extract of Korean medicine |
| CN2012105564143A CN103156798A (en) | 2011-12-19 | 2012-12-19 | Cosmetic composition for anti-oxidation or skin whitening containing extract of medicinal herbs mixture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110137197A KR101904800B1 (en) | 2011-12-19 | 2011-12-19 | Cosmetic composition for anti-oxidation or skin whintening containing extract of medicinal herbs mixture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20130070062A KR20130070062A (en) | 2013-06-27 |
| KR101904800B1 true KR101904800B1 (en) | 2018-10-10 |
Family
ID=48580667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020110137197A Expired - Fee Related KR101904800B1 (en) | 2011-12-19 | 2011-12-19 | Cosmetic composition for anti-oxidation or skin whintening containing extract of medicinal herbs mixture |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP6154606B2 (en) |
| KR (1) | KR101904800B1 (en) |
| CN (1) | CN103156798A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105168256A (en) * | 2015-09-08 | 2015-12-23 | 浙江海洋学院 | Zymolytic tuna tablet for beautifying and fighting against free radicals and preparation method of zymolytic tuna tablet |
| CN105708771A (en) * | 2016-04-25 | 2016-06-29 | 温州博远工业设计有限公司 | Formula and preparation technology of skin-whitening and beautifying effective composition |
| CN114522125B (en) * | 2022-03-07 | 2023-05-16 | 广州睿森生物科技有限公司 | Anti-aging composition and application thereof in cosmetics |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10265321A (en) * | 1997-03-19 | 1998-10-06 | Shiseido Co Ltd | Skin preparation for external use |
| JP2002179516A (en) * | 2000-12-13 | 2002-06-26 | Pola Chem Ind Inc | Skin-whitening composition |
| JP3583108B2 (en) * | 2002-03-14 | 2004-10-27 | 株式会社ノエビア | External preparation for skin |
| JP2003171310A (en) * | 2002-05-02 | 2003-06-20 | Noevir Co Ltd | Skin barrier function-reinforcing agent |
| JP2005112793A (en) * | 2003-10-08 | 2005-04-28 | Norihide Yamaguchi | Bleaching cosmetic |
| JP2006111545A (en) * | 2004-10-13 | 2006-04-27 | Nippon Menaade Keshohin Kk | Glutathione reductase activity-enhancing agent |
| JP2006206513A (en) * | 2005-01-28 | 2006-08-10 | Nippon Menaade Keshohin Kk | Skin care preparation |
| KR20090130584A (en) * | 2008-06-16 | 2009-12-24 | (주)코바스 | Cosmetic composition for skin whitening and wrinkle improvement containing complex herbal extract as an active ingredient |
| KR101059471B1 (en) * | 2008-07-22 | 2011-08-25 | 주식회사 바이오랜드 | Cosmetic composition for skin aging |
| CN101675914A (en) * | 2008-09-19 | 2010-03-24 | 郭晓宇 | Mask |
| KR20110088978A (en) * | 2010-01-29 | 2011-08-04 | 애경산업(주) | Oral composition containing herbal extract |
| KR20110121487A (en) * | 2010-04-30 | 2011-11-07 | 대구가톨릭대학교산학협력단 | Anti-oxidant and Anti-inflammatory Herbal Medicine Extract Containing Eugellet-Inducer Derivatives and Manufacturing Method Thereof |
| CN102198078B (en) * | 2011-05-23 | 2014-02-12 | 昆明理工大学 | A kind of foam type facial cleanser containing traditional Chinese medicine and preparation method thereof |
-
2011
- 2011-12-19 KR KR1020110137197A patent/KR101904800B1/en not_active Expired - Fee Related
-
2012
- 2012-12-17 JP JP2012274402A patent/JP6154606B2/en not_active Expired - Fee Related
- 2012-12-19 CN CN2012105564143A patent/CN103156798A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20130070062A (en) | 2013-06-27 |
| JP6154606B2 (en) | 2017-06-28 |
| CN103156798A (en) | 2013-06-19 |
| JP2013126980A (en) | 2013-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Das et al. | Cactus: Chemical, nutraceutical composition and potential bio‐pharmacological properties | |
| KR101829892B1 (en) | A cosmetic composition comprising fraxinus rhynchophylla extract and calystegia soldanella extract | |
| JPH0717845A (en) | Skin external preparation | |
| Kozak et al. | Health properties of selected herbal plants | |
| KR101829891B1 (en) | A cosmetic composition comprising osmanthus asiaticus extract and clematis apiifolia extract | |
| KR102791762B1 (en) | Whitening cosmetic composition containing mixed extract peony, locust tree, blue lotus, saffron, cornflower using Lactobaciilus brevis | |
| KR101904800B1 (en) | Cosmetic composition for anti-oxidation or skin whintening containing extract of medicinal herbs mixture | |
| KR101456059B1 (en) | The cosmetic composition effective in whitening and anti-aging mainly comprised of roasted licorice extract | |
| KR102561149B1 (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR102573375B1 (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR101793104B1 (en) | Cosmetic composition for whitening skin comprising mixed extract of Cudrania tricuspidata leaf and Morus alba leaf as effective component | |
| KR20170137405A (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR101827655B1 (en) | A composition comprising banana having inhibitory effect on induction of grey hair and positive effect on induction of black hair | |
| JPH0525849B2 (en) | ||
| KR102289943B1 (en) | Cosmetic composition containing complex extracts of Chrysanthemum Sibiricum, Viscum Album, Selaginella Tamariscina, Portulaca Oleracea and Perilla Frutescens | |
| KR20010093861A (en) | Whitening composition including the extract of the fruits of Melia azedarach or M. toosendan | |
| KR102041543B1 (en) | Cosmetic composition for skin moisturizing and anti-wrinkle comprising herbal medicine mixed extract as effective component | |
| KR102573376B1 (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR102561150B1 (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR102503191B1 (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR102585725B1 (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR101769123B1 (en) | Cosmetic composition containing natural complex extract for improving atopic dermatitis | |
| KR20140115229A (en) | Composition comprising oriental herbal extracts having antioxidant or whitening effect | |
| KR100345225B1 (en) | Whitening cosmetic composition including the extract of the fruit of Evodia officinalis, E. rutaecarpa | |
| KR102504878B1 (en) | cosmetic composition having anti-inflammatory and skin soothing and effects and improvement of skin itching containing fermented extracts of Campsis grandiflora, Plum blossom, Quercus acuta THUNB |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R11-asn-PN2301 St.27 status event code: A-3-3-R10-R13-asn-PN2301 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| AMND | Amendment | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |
|
| AMND | Amendment | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PX0901 | Re-examination |
St.27 status event code: A-2-3-E10-E12-rex-PX0901 |
|
| PX0701 | Decision of registration after re-examination |
St.27 status event code: A-3-4-F10-F13-rex-PX0701 |
|
| X701 | Decision to grant (after re-examination) | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
Fee payment year number: 1 St.27 status event code: A-2-2-U10-U11-oth-PR1002 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
| PC1903 | Unpaid annual fee |
Not in force date: 20210929 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE St.27 status event code: A-4-4-U10-U13-oth-PC1903 |
|
| PC1903 | Unpaid annual fee |
Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20210929 St.27 status event code: N-4-6-H10-H13-oth-PC1903 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R11-asn-PN2301 St.27 status event code: A-5-5-R10-R13-asn-PN2301 |
